弱毒化生ワクチン市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00004591
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Live Attenuated Vaccines Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

市場紹介
弱毒生ワクチンは、ワクチン接種を受けた人の体内で増殖できるレベルに弱毒化された病原体から製造されますが、病気の形成は引き起こしないか軽度です。これらのワクチンは、ワクチン接種を受けた人が同じ病気にかかるのを防ぐ免疫反応の生成に役立ちます。 WHO が推奨している BCG、ポリオ ワクチン、麻疹、ロタウイルス、黄熱病などのワクチンは弱毒化によって製造されています。

市場のダイナミクス
弱毒化生ワクチン市場が期待されています。ワクチン接種に対する意識、政府による助成金の増額、子どもへのワクチン接種の義務化に向けた措置により、予測期間中に増加するとみられる。さらに、感染症の発生の増加は市場の機会を提供しています。

市場範囲
「2031年までの世界の弱毒化生ワクチン市場分析」は、製薬業界の専門的かつ詳細な調査であり、特に次のことに焦点を当てています。世界市場のトレンド分析。このレポートは、種類、エンドユーザー、地域ごとの詳細な市場分割とともに、弱毒生ワクチン市場の概要を提供することを目的としています。世界の弱毒化生ワクチン市場は、予測期間中に高い成長を遂げると予想されます。このレポートは、弱毒生ワクチン市場の主要企業の市場状況に関する重要な統計を提供し、市場の主要な傾向と機会を提供します。

市場セグメンテーション
グローバル弱毒化生ワクチン市場は、種類とエンドユーザーに基づいて分割されています。種類に基づいて、市場はウイルスと細菌に分類されます。エンドユーザーに基づいて、市場は病院、診療所、研究機関、その他のエンドユーザーに分類されます。

Live Attenuated Vaccines Market: Strategic Insights

Live Attenuated Vaccines Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Emergent BioSolutions Inc
  • GlaxoSmithKline plc
  • BioDiem
  • AstraZeneca
  • Merck Co Inc
  • Pfizer Inc
  • Sanofi
  • Serum institute of India Pvt Ltd
  • CSL Limited

Regional Overview

Regional And Country Scope
  • 北米
  • ヨーロッパ
  • アジア太平洋
  • 南米および中米
  • 中東およびアフリカ

Market Segmentation

Segment 1種類
  • ウイルスおよび細菌
Segment2エンドユーザー
  • 病院
  • 診療所
  • 研究機関
  • その他のエンドユーザー
Segment3地理
  • 北アメリカ
  • ヨーロッパ
  • アジア太平洋
  • 南アメリカ
  • 中央アメリカ

このレポートでは、市場の詳細な概要が提供されます。定性的および定量的な情報の両方を含む業界。さまざまなセグメントに基づいた世界の弱毒化生ワクチン市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南および南。中米。各地域ごとの弱毒生ワクチン市場は、その後、それぞれの国およびセグメントごとにサブセグメント化されます。このレポートは、世界 18 か国の分析と予測、およびこの地域で広まっている現在の傾向と機会をカバーしています。

レポートは、需要側と供給側の両方から弱毒生ワクチン市場に影響を与える要因を分析し、影響を与える市場力学をさらに評価します。予測期間中の市場、つまり推進要因、制約、機会、将来の傾向。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、南および南。中米では、これらの地域の弱毒生ワクチン市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。

市場参加者
レポートは、有機的および無機的成長戦略としての弱毒生ワクチン市場の主要な動向をカバーしています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略活動は、買収、提携および提携でした。コラボレーション。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。世界市場における弱毒生ワクチン市場の需要の高まりに伴い、弱毒生ワクチン市場からの支払者は、将来的に有利な成長機会が期待されています。以下に記載するのは、弱毒化生ワクチン市場に従事する数社のリストです。

このレポートには、主要な弱毒生ワクチン市場企業の概要と、SWOT分析および市場戦略も含まれています。さらに、このレポートは業界の主要企業に焦点を当て、会社概要、提供されるコンポーネントとサービス、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報を提供します。
  • Emergent BioSolutions Inc.
  • グラクソ・スミスクライン plc
  • バイオディエム
  • アストラゼネカ
  • メルク&株式会社
  • ファイザー株式会社
  • サノフィ
  • インド血清研究所Ltd.
  • CSL Limited
  • Vivaldi Biosciences Inc.
Insight Partner の専任研究分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成され、さまざまなカスタマイズを提供します既存のスタディのオプション。

Live Attenuated Vaccines Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 種類
  • ウイルスおよび細菌
By エンドユーザー
  • 病院
  • 診療所
  • 研究機関
  • その他のエンドユーザー
By 地理
  • 北アメリカ
  • ヨーロッパ
  • アジア太平洋
  • 南アメリカ
  • 中央アメリカ
Regions and Countries Covered 北米
  • 米国
  • カナダ
  • メキシコ
ヨーロッパ
  • 英国
  • ドイツ
  • フランス
  • ロシア
  • イタリア
  • その他のヨーロッパ
アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他のアジア太平洋
南米および中米
  • ブラジル
  • アルゼンチン
  • その他の中南米
中東およびアフリカ
  • 南アフリカ
  • サウジアラビア
  • UAE
  • その他の中東およびアフリカ
Market leaders and key company profiles
  • Emergent BioSolutions Inc
  • GlaxoSmithKline plc
  • BioDiem
  • AstraZeneca
  • Merck Co Inc
  • Pfizer Inc
  • Sanofi
  • Serum institute of India Pvt Ltd
  • CSL Limited
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Emergent BioSolutions Inc.
    2. GlaxoSmithKline plc
    3. BioDiem
    4. AstraZeneca
    5. Merck & Co., Inc.
    6. Pfizer Inc.
    7. Sanofi
    8. Serum institute of India Pvt. Ltd.
    9. CSL Limited
    10. Vivaldi Biosciences Inc.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..